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A B S T R A C T
Background
Non-specific cough has been defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology and
is common in childhood. These children are treated with a variety of therapies, including non-pharmacological treatments. There is a
wide variety and a growing market for these non-pharmacological treatments that include air-modification modalities.
Objectives
To determine the efficacy of air-modification modalities, (ionisers, vaporisers, humidifiers, air filters, regular vacuuming), in treating
children with non-specific cough.
Search methods
TheCochraneCentral Register of ControlledTrials (CENTRAL),MEDLINE,OLDMEDLINE andEMBASEdatabases were searched
by the Cochrane Airways Group. The latest searches were performed in November 2008.
Selection criteria
All randomised controlled trials comparing air-modification modalities with a placebo treatment, for any duration.
Data collection and analysis
Results of searches were reviewed against pre-determined criteria for inclusion. Five papers were considered for inclusion but no eligible
trials were identified and thus no data was available for analysis.
Main results
No randomised controlled trials that examined the efficacy of air-modification modalities in themanagement of prolonged, non-specific
cough in children were found.
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Authors’ conclusions
Based on the evidence currently available, a recommendation can not be given for air-modification interventions in the treatment of
prolonged, non-specific cough in children.
P L A I N L A N G U A G E S U M M A R Y
Indoor air modification interventions for prolonged non-specific cough in children
Prolonged, non-specific cough is common in childhood and is treated with a variety of therapies. There is a growing market for
non-pharmacological treatments and these include air-modification modalities, (ionisers, vaporisers, humidifiers, air filters and regular
vacuuming). No randomised controlled trials examining the efficacy of air-modulation modalities in the management of prolonged,
non-specific cough in children were found. Therefore, based on the evidence currently available, a recommendation for these treatments
cannot be given. Due to the popularity of air-modulation modalities, randomised controlled trials in this area are clearly needed.
B A C K G R O U N D
Cough is a very common and troublesome symptom of respiratory
disease. Non-specific cough has been defined as non-productive
cough in the absence of identifiable respiratory disease or known
aetiology (Chang 2001) and is common in childhood. The ma-
jority of these children have no signs of other current disease pro-
cesses and, in the absence of research to guide clinical practice, are
treated with a variety of therapies. They present a major manage-
ment problem and cause considerable anxiety to parents.
Treatment of cough is problematic, and many over-the-counter
medications are readily available and widely used. These include
anti-tussives, mucolytics and anti-histamines, though there is no
good evidence for their effectiveness (Schroeder 2002). Two ran-
domised controlled trials have been carried out on the use of
asthma medication, (inhaled salbutamol and corticosteroids), in
children with isolated, chronic cough, but neither recommended
using these therapies (Chang 1998, Davies 1999). Antibiotics are
frequently prescribed with variable effect. Difficulties in the inter-
pretation of drug trials lie in the fact that cough usually resolves
spontaneously, i.e. the period effect.
Non-pharmacological treatments, to compliment pharmacologi-
cal therapies, are also very popular. There is a wide variety avail-
able and this is a growing market. These include air modifiers, e.g.
ionisers, vaporisers, humidifiers, air filters, regular vacuuming and
other methods for dust reduction, which are mainly used in the
home. Ionisers remove particles from the air, which are likely to in-
clude airborne allergens and smoke particles, via electrostatic pre-
cipitation. A previous Cochrane review on ionisers in asthma con-
cluded that their use cannot be recommended, (Blackhall 2003).
One study reviewed showed an increase in the frequency of night-
time cough during the ionisation period and recommended that
this be looked at further (Warner 1993). Many of these thera-
pies are carried out without good evidence for their use. There is
a paucity of randomised controlled trials in this area, and many
studies in the literature are based on case reports. A systematic
review examining the efficacy of air modification modalities for
prolonged, non-specific cough in children would be useful.
O B J E C T I V E S
To determine the efficacy of air modification interventions, (ionis-
ers, vaporisers, humidifiers, air filters, regular vacuuming), in treat-
ing children with non-specific cough.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials comparing non-pharmacological
treatments with a placebo treatment.
Types of participants
All trials which included children under 18 years of age with pro-
longed (3 or more weeks) non-specific cough (dry and non-pro-
ductive cough without any other respiratory symptom, sign or
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systemic illness). An a priori subgroup analysis was planned for
children < 7 years of age.
Exclusion criteria: cough related to mycoplasma, pertussis and
chlamydia, presence of underlying cardio-respiratory condition,
current or recurrent wheeze (>2 episodes), presence of other res-
piratory symptoms (productive cough, haemoptysis, dyspnoea),
presence of other respiratory signs (clubbing, chest wall deformity,
respiratory noises such as wheeze on auscultation and other ad-
ventitious sounds), presence of any sign of systemic illness (failure
to thrive, aspiration, neurological or developmental abnormality),
presence of lung function abnormality.
Types of interventions
All randomised controlled comparisons of air modification inter-
ventions versus placebo treatments in the management of non-
specific cough. It was planned that trials only comparing two or
more treatments without a placebo comparison group would not
be included.
Trials that included the use of other medications or interventions
were included if all participants had equal access to such medica-
tions or interventions.
The following interventions were evaluated;
a) ionisers (positive and negative)
b) vaporisers,
c) humidifiers,
d) air filters,
e) regular vacuuming,
f ) other dust reduction methods (change of carpets, dust covers
etc).
Types of outcome measures
Primary outcomes
Proportions of participantswhowere not cured or not substantially
improved at follow up (clinical failure).
Secondary outcomes
1. proportions of participants who were not cured at follow
up,
2. proportions of participants who not substantially improved
at follow up,
3. mean difference in cough indices (cough diary, cough
frequency, cough scores),
4. proportions experiencing adverse effects, e.g. behavioural
changes, nausea, bronchospasm, hypersensitivity, burns, (side
effects),
5. proportions experiencing complications e.g. requirement
for medication change
The proportions of participants who failed to improve on treat-
ment and the mean clinical improvement was determined using
the following hierarchy of assessment measures (i.e.. where two or
more assessment measures were reported in the same study, the
outcome measure that was listed first in the hierarchy was used).
i) Objective measurements of cough indices (cough frequency,
cough receptor sensitivity, cough amplitude).
ii) Symptomatic (Likert scale, visual analogue scale, level of inter-
ference of cough, cough diary) - assessed by the child.
iii) Symptomatic (Likert scale, visual analogue scale, level of inter-
ference of cough, cough diary) - assessed by the parents/carers.
iv) Symptomatic (Likert scale, visual analogue scale, level of inter-
ference of cough, cough diary) - assessed by clinicians.
v) Airway markers consistent with infection or inflammation.
Search methods for identification of studies
The following topic search strategy was used to identify relevant
randomised controlled trials listed from the electronic databases:
(cough [MeSH] OR cough [text word] OR bronchitis [MeSH]
OR bronchitis [text word]) AND (ioniser [MeSH] OR ioniser
[text word] or electrostatic precipitator [MeSH] OR electrostatic
precipitator [text word] OR vapouriser [MeSH] OR vapouriser
[text word] OR humidifier [MeSH] OR humidifier [text word]
OR air filter [MeSH]ORair filter [text word]OR regular vacuum-
ing [MeSH] OR regular vacuuming [text word] OR dust [MeSH]
or dust [text word] OR indoor air [MeSH] or indoor air [text
word] AND children or child [Mesh or text word].
The full search strategies are listed in Appendix 1.
Trials were identified from the following sources:
1. The Cochrane Central Register of Controlled Trials (CEN-
TRAL Issue 4/2008), which includes theCochraneAirwaysGroup
Specialised Trials Register.
2. MEDLINE (1966 - Nov 2008). Topic search strategy com-
bined with the RCT search filter as outlined in the Airways Group
module.
3. OLDMEDLINE (1950-1965). Topic search strategy combined
with the RCT search filter as outlined in the Airways Group mod-
ule.
4. EMBASE (1980 - Nov 2008).Topic search strategy combined
with the RCT search filter as outlined in the Airways Group mod-
ule.
5. The list of references in relevant publications.
6. Written communication with the authors of trials included in
the review.
Data collection and analysis
Selection of studies
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From the title, abstract, or descriptors, three reviewers (DED, ME
&ABC) independently reviewed literature searches to identify po-
tentially relevant trials for full review. Searches of bibliographies
and texts were conducted to identify additional studies. From the
full text, using specific criteria, the same two reviewers indepen-
dently selected trials for inclusion. Agreement was measured using
kappa statistics, where appropriate. Disagreement was resolved by
consensus.
Data extraction and management
Trials that satisfied the inclusion criteria were to be reviewed and
the following information recorded: study setting, year of study,
source of funding, patient recruitment details (including number
of eligible children), inclusion and exclusion criteria, randomisa-
tion and allocation concealment method, numbers of participants
randomised, blinding (masking) of participants, care providers and
outcome assessors, type of non-pharmacological therapy used, du-
ration of therapy, co-interventions, numbers of patients not fol-
lowed up, reasons for withdrawals from study protocol (clinical,
side-effects, refusal and other), details on side-effects of therapy,
and whether intention-to-treat analyses were possible. Data was
to be extracted on the outcomes described previously. Further in-
formation was to be requested from the authors where required.
Assessment of risk of bias in included studies
Studies included in the review were to undergo quality assessment
performed independently by all reviewers. Four components of
quality were to be assessed:
1. Allocation concealment. Trials were to be scored as: Grade A:
Adequate concealment, Grade B: Unclear, Grade C: Clearly inad-
equate concealment. (Grade A = high quality).
2. Blinding. Trials were to be scored as: Grade A: Participant and
care provider and outcome assessor blinded, Grade B: Outcome
assessor blinded, Grade C: Unclear, Grade D: No blinding of out-
come assessor (Grade A, B = high quality).
3. Reporting of participants by allocated group. Trials were to be
scored as: Grade A: The progress of all randomised children in each
group described, Grade B: Unclear or no mention of withdrawals
or dropouts, Grade C: The progress of all randomised children in
each group clearly not described. (Grade A = high quality).
4. Follow-up. Trials were to be scored as: Grade A: Outcomes
measured in >90% (where withdrawals due to complications and
side-effects are categorised as treatment failures), Grade B: Out-
comes measured in 80-90%, Grade C: Unclear, Grade D: Out-
comes measured in <80%. (Grade A = high quality).
While only the allocation concealment quality assessment was to
be displayed in themeta-analysis figures, all assessments were to be
included in the “Characteristics of included studies” table. Inter-
reviewer reliability for the identification of high quality studies for
each component was to be measured by the Kappa statistic.
Each study was to be also assessed using a 1 to 5 scale described
by Jadad 1996, and summarised as follows:
Was the study described as randomised? (1=yes; 0=no)
Was the study described as double blind? (1=yes; 0=no)
Was there a description of withdrawals and dropouts? (1=yes; 0=
no)
Was the method of randomisation clearly described and appropri-
ate? (1=yes; 0=no)
Was the method of double blinding well described and appropri-
ate? (1=yes; 0=no)
Data synthesis
For the dichotomous outcome variables of each individual study,
relative and absolute risk reductions were to be calculated using
a modified intention-to-treat analysis. This analysis assumes that
children not available for outcome assessment have not improved
(and probably represents a conservative estimate of effect). An ini-
tial qualitative comparison of all the individually analysed stud-
ies was to examine whether pooling of results (meta-analysis) was
reasonable. This took into account differences in study popula-
tions, inclusion/exclusion criteria, interventions, outcome assess-
ment, and estimated effect size.
The results from studies that met the inclusion criteria and re-
ported any of the outcomes of interest were to be included in the
subsequent meta-analyses. The summary weighted risk ratio and
95%confidence interval (fixed effectsmodel) were to be calculated
using the inverse of the variance of each study result for weighting
(Cochrane statistical package, RevMan version 4.1). The number
needed to treat was to be calculated using the summary odds ratio
and the average control event rate described in the relevant studies.
The cough indices were assumed to be normally distributed, con-
tinuous variables so the mean difference in outcomes could be es-
timated (weighted mean difference). If studies reported outcomes
using different measurement scales, the standardised mean differ-
ence was to be estimated. Any heterogeneity between the study
results was to be described and tested to see if it reached statistical
significance using a chi-squared test. The 95% confidence interval
estimated using a random effects model was to be included when-
ever there were concerns about statistical heterogeneity.
Subgroup analysis and investigation of heterogeneity
A priori sub-group analysis was planned by study populations
(children less than 7 years of age, and children over 7 years of age)
and by interventions:
1. ionisers (positive and negative),
2. vaporisers,
3. humidifiers,
4. air filters,
5. regular vacuuming,
6. other dust reduction modalities.
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Sensitivity analysis
Sensitivity analyses were planned to assess the impact of the poten-
tially important factors on the overall outcomes: a) study quality;
b) study size; c) variation in the inclusion criteria; d) differences in
the medications used in the intervention and comparison groups;
e) differences in outcome measures; and f ) analysis by “treatment
received” rather than “intention-to-treat”.
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
The searches identified five potential studies, none fulfilled the
study eligibility criteria, i.e. none were related to cough and most
were related to asthma and allergy, particularly house dust mite
and mould.
Risk of bias in included studies
Not applicable.
Effects of interventions
The Airway Group search identified 600 potentially relevant ti-
tles. After assessing the abstracts, five studies were considered for
inclusion into review. None of the studies fulfilled study criteria.
D I S C U S S I O N
No randomised controlled trials comparing interventions of air
modification in children with non-specific cough were identified.
Cohort studieswere also not available and thus no guide is available
to guide any time response.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the evidence currently available from randomised con-
trolled trials, a recommendation can not be given for air modifi-
cation interventions in the treatment of prolonged, non-specific
cough in children.
Implications for research
Given the popularity of air modification interventions, ran-
domised controlled trials of these interventions to determine
the effectiveness in treating children with non-specific cough are
clearly needed. Trials should be parallel studies and double blind,
given the known problems in studying cough, specifically the large
placebo and time period effects (Chang 1999). Outcomemeasures
for the clinical studies on cough should be clearly defined using
validated subjective data and supported by objective data when
possible.
A C K N OW L E D G E M E N T S
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Mr. Toby Lasserson and Dr Chris Cates of the Cochrane Airways
Group.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Chervinskaya 1995 Study on halotherapy, given to adults in a halochamber
Daugbjerg 1988 Adult study in asthmatic patients, using ion generators
Huang 1995 Study of children with perennial rhinitis and mould allergy, given air cleaners in the bedroom
Warner 1993 Study of asthmatic children sensitive to house dust mite, given ionisers in the living room during the day, and
in the bedroom at night
Zwemer 1973 Study of asthmatic children sensitive to house dust mite, given an air filter in the bedroom
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL MEDLINE EMBASE
#1. COUGH
#2. BRONCHITIS
#3. (cough* or bronchit*)
#4. (#1 or #2 or #3)
#5. AIR IONIZATION
#6. (ioniser* or ionizer*)
#7. NEBULIZERS AND VAPORIZERS
#8. (vaporizer* or vaporiser* or vapourizer*
or vapouriser*)
#9. HUMIDITY
#10. humidif*
#11. FILTRATION
#12. (air near filter*)
#13. (air near filtrat*)
#14. HOUSEKEEPING
#15. FLOORS AND FLOORCOVER-
INGS
#16. (vacuuming or hoover*)
#17. (vacuum* near clean*)
#18. DUST
#19. dust*
#20. (electrostatic near precipitat*)
#21. AIR POLLUTION INDOOR
#22. (indoor near air)
#23. (#5 or #6 or #7 or #8 or #9 or #10 or
#11 or #12 or #13 or #14 or #15 or #16 or
#17 or #18 or #19 or #20 or #21 or #22)
#24. (#23 and #4)
1. exp COUGH/
2. exp BRONCHITIS/
3. (cough$ or bronchit$).mp.
4. or/1-3
5. exp AIR IONIZATION/
6. (ioniser$ or ionizer$).mp.
7. exp “NEBULIZERS AND VAPORIZ-
ERS”/
8. (vapori#er$ or vapouri#er$).mp.
9. exp HUMIDITY/
10. humidif$.mp.
11. exp FILTRATION/
12. (air adj3 (filter$ or filtrat$)).mp.
13. HOUSEKEEPING/
14. exp “FLOORS AND FLOORCOV-
ERINGS”/
15. (vacuuming or hoovering or (vacuum$
adj3 clean$)).mp.
16. exp DUST/
17. dust$.mp
18. (electrostatic adj3 precipitat$).mp.
19. exp AIR POLLUTION, INDOOR/
20. (indoor$ adj3 air).mp.
21. or/5-20
22. 4 and 21
(This search is combined with a RCT filter
as outline in the Airways Group Module)
1. exp COUGHING/
2. exp Bronchitis/
3. (cough$ or bronchit$).mp.
4. or/1-3
5. exp air/
6. (ioniser$ or ionizer$).mp.
7. exp vaporizer/
8. exp Humidifier/
9. (vapori#er$ or vapouri#er$).mp.
10. humidif$.mp.
11. exp FILTRATION/
12. (air adj3 (filter$ or filtrat$)).mp.
13. household/
14. exp Cleaning/
15. (vacuuming or hoover$ or (vacuum$
adj3 clean)).mp.
16. exp dust/
17. dust$.mp.
18. (electrostatic adj3 precipitat$).mp.
19. exp indoor air pollution/
20. (indoor$ adj3 air).mp.
21. or/5-20
22. 4 and 21
(This search is combined with a RCT filter
as outline in the Airways Group Module)
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WH A T ’ S N E W
Last assessed as up-to-date: 20 January 2009.
Date Event Description
21 January 2009 New search has been performed Literature search re-run; no new studies identified
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 3, 2006
Date Event Description
28 July 2008 Amended Converted to new review format.
3 May 2006 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
DD wrote the protocol based on previous protocols for treatment of non specific cough in children. ME and AC contributed to the
protocol generation and guided the process. For the review, DD, ME and AC selected abstracts on the search conducted by Liz Arnold
of the Cochrane Airways Group. All contributed to writing of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Air Pollution, Indoor [adverse effects; ∗prevention & control]; Cough [etiology; ∗prevention & control]; Filtration [instrumentation];
Housekeeping [methods]; Humidity; Nebulizers and Vaporizers; Vacuum
9Indoor air modification interventions for prolonged non-specific cough in children (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
MeSH check words
Child; Humans
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